Overview

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study efficacy and safety of cilostazol use in patients with acute ischemic stroke.
Phase:
Phase 4
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.
Collaborators:
Korea Otsuka International Asia Arab Co., Ltd.
Seoul National University Boramae Hospital
Treatments:
Aspirin
Cilostazol